Remedy Meds to Acquire Thirty Madison in All-Stock Deal Valued at Over $500 Million
September 8, 2025
Remedy Meds announced a definitive agreement to acquire Thirty Madison in an all-stock transaction valued at just over $500 million. The deal is expected to close in the fourth quarter of 2025, pending regulatory approvals and standard closing conditions.
- Buyers
- Remedy Meds
- Targets
- Thirty Madison
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
CorMedix Acquires Melinta Therapeutics for $300 Million
August 7, 2025
Biotechnology
CorMedix Inc. has entered into a definitive agreement to acquire Melinta Therapeutics, paying $300 million upfront (including $260 million cash and $40 million in CorMedix equity to Melinta shareholders), plus up to $25 million in a regulatory milestone and tiered royalties. The deal is expected to close in September, subject to customary closing conditions and U.S. regulatory approval.
-
Medicure Inc. Acquires Marley Drug, Inc.
December 15, 2020
Healthcare Services
Medicure Inc., through its wholly-owned U.S. subsidiary Medicure Pharma Inc., agreed to acquire 100% of Marley Drug, Inc., a specialty mail-order pharmacy based in North Carolina, for an upfront USD $6.3 million plus contingent payments. Marley serves over 30,000 customers nationwide, generated approximately $7.0 million of revenue and more than $1.7 million of EBITDA for the 12 months ended October 31, 2020, and the acquisition expands Medicure's direct-to-patient distribution and specialty pharmacy capabilities in the United States.
-
Amulet Capital Partners Acquires Remedy Health Media
September 27, 2021
Healthcare Services
Amulet Capital Partners, a Greenwich, Connecticut-based private equity firm focused on healthcare, has acquired Remedy Health Media from Topspin Consumer Partners. Amulet will partner with Remedy's management to accelerate growth organically and via strategic M&A, using Remedy as a platform investment from its recently closed Fund II.
-
Brown & Brown, Inc. Acquires Remedy Analytics, Inc.
October 19, 2021
Healthcare Services
Brown & Brown, Inc. acquired all outstanding stock of Remedy Analytics, a Milwaukee-based pharmacy consulting and analytics firm that operates the PharmaLogic medication platform. Remedy Analytics will continue operating from Milwaukee within Brown & Brown's Retail segment to expand the firm's pharmacy consulting and data-driven benefits capabilities for employer clients.
-
VillageMD to Acquire Summit Health-CityMD for ~$8.9B
November 7, 2022
Healthcare Services
VillageMD entered a definitive agreement to acquire Summit Health-CityMD, a provider of primary, specialty, and urgent care, in a transaction valued at approximately $8.9 billion. Walgreens Boots Alliance will invest $3.5 billion and will remain the largest shareholder, while Evernorth (an affiliate of Cigna) will take a minority ownership position in the combined company. The deal is expected to close in the first quarter of 2023.
-
ADDvise Group AB Acquires Medisuite, LLC
July 30, 2021
Pharmaceuticals
ADDvise Group AB has entered into a share purchase agreement to acquire all outstanding shares of Medisuite, LLC, an online pharmacy based in Cary, North Carolina that specializes in men's health medications. The purchase price is approximately USD 10.3 million (combination of cash, a promissory note and potential earn-outs); closing is expected in August 2021 and the acquisition is financed with ADDvise's own funds.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.